Sobha Sivaprasad Selected Research

Geographic Atrophy

11/2023	The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: A living systematic review and meta-analysis.
10/2023	Systematic review of prognostic factors associated with progression to late age-related macular degeneration: Pinnacle study report 2.
1/2021	Prevalence and phenotype associations of complement factor I mutations in geographic atrophy.
7/2017	Retinal angiomatous proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sobha Sivaprasad Research Topics

Disease

75	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2024 - 08/2008
58	Macular Degeneration (Age-Related Maculopathy) 05/2024 - 09/2005
37	Macular Edema 10/2023 - 11/2008
16	Retinal Vein Occlusion 07/2023 - 11/2010
13	Type 2 Diabetes Mellitus (MODY) 01/2023 - 08/2008
11	Central Serous Chorioretinopathy 04/2023 - 11/2010
7	Atrophy 01/2024 - 08/2010
7	Ganglion Cysts (Ganglion) 12/2023 - 01/2015
7	Choroidal Neovascularization 04/2023 - 09/2013
6	Ischemia 04/2024 - 05/2014
6	Vascular Diseases (Vascular Disease) 01/2024 - 11/2010
5	Retinal Diseases 01/2023 - 03/2014
4	Geographic Atrophy 11/2023 - 07/2017
4	Vision Disorders (Hemeralopia) 01/2022 - 01/2015
4	Glaucoma 01/2022 - 03/2014
4	Diabetes Mellitus 01/2021 - 08/2016
4	Cataract (Cataracts) 01/2021 - 02/2012
4	Inflammation (Inflammations) 01/2017 - 07/2010
3	Prediabetic State (Prediabetes) 04/2024 - 01/2022
3	Retinal Perforations 01/2023 - 07/2016
3	Blindness (Hysterical Blindness) 12/2022 - 03/2019
3	Retinal Neovascularization 10/2022 - 01/2019
3	Telangiectasis (Telangiectasia) 01/2022 - 01/2017
3	Hyperglycemia 01/2021 - 09/2011
3	Cysts 01/2020 - 11/2007
3	Epilepsy (Aura) 01/2017 - 01/2016
3	Hypoxia (Hypoxemia) 01/2016 - 09/2011
2	Fibrosis (Cirrhosis) 01/2024 - 08/2010
2	Vitreous Hemorrhage 04/2023 - 01/2018
2	Myopia 04/2023 - 01/2019
2	Endophthalmitis (Ophthalmia) 03/2023 - 01/2020
2	Arteriosclerosis 01/2023 - 01/2021
2	Disease Progression 01/2023 - 01/2023
2	Eye Diseases (Eye Disease) 01/2022 - 12/2017
2	Hypertension (High Blood Pressure) 12/2021 - 01/2015
2	Polypoidal Choroidal Vasculopathy 01/2021 - 12/2018
2	Mydriasis 01/2021 - 01/2020
2	Retinal Hemorrhage 01/2020 - 01/2019
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2019 - 11/2010
2	Edema (Dropsy) 01/2019 - 03/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 02/2013
2	Cognitive Dysfunction 01/2016 - 10/2013
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2024
1	Hemorrhage 01/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023
1	Parkinson Disease (Parkinson's Disease) 11/2023
1	Hyperinsulinism (Hyperinsulinemia) 12/2022
1	Chronic Renal Insufficiency 11/2022
1	Uveitis 01/2022
1	Carotid-Cavernous Sinus Fistula 01/2022

Drug/Important Bio-Agent (IBA)

80	Retinaldehyde (Retinal)IBA 04/2024 - 11/2007
37	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 03/2011
31	afliberceptIBA 05/2024 - 09/2015
31	Ranibizumab (Lucentis)FDA Link 04/2023 - 08/2010
13	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2020
9	Fluorescein (Funduscein)FDA LinkGeneric 10/2022 - 03/2011
7	Bevacizumab (Avastin)FDA Link 04/2023 - 09/2013
5	Eplerenone (Inspra)FDA LinkGeneric 04/2023 - 01/2019
5	Complement Factor H (Factor H)IBA 01/2021 - 04/2007
4	Mydriatics (Cycloplegics)IBA 02/2024 - 10/2019
4	Dexamethasone (Maxidex)FDA LinkGeneric 06/2023 - 12/2016
4	N-acetyltryptophanamide (NATA)IBA 01/2023 - 01/2015
4	Retinal Pigments (Pigments, Visual)IBA 01/2022 - 08/2010
3	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2022
3	SteroidsIBA 12/2022 - 01/2015
3	Endothelial Growth FactorsIBA 12/2021 - 10/2020
3	pegaptanib (Macugen)FDA Link 01/2014 - 06/2008
2	Complement System Proteins (Complement)IBA 11/2023 - 04/2007
2	Complement C3 (C3 Complement)IBA 11/2023 - 04/2007
2	LipidsIBA 01/2023 - 01/2017
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 01/2022
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 07/2017
2	Macular PigmentIBA 01/2022 - 01/2016
2	Insulin (Novolin)FDA Link 12/2021 - 08/2016
2	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2020 - 01/2019
2	Mitochondrial DNA (mtDNA)IBA 01/2019 - 12/2015
2	Oxygen (Dioxygen)IBA 01/2018 - 11/2014
1	faricimabIBA 12/2023
1	Tyrosine Kinase InhibitorsIBA 12/2023
1	Verteporfin (Visudyne)FDA Link 04/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2023
1	formycin diphosphate (FDP)IBA 01/2023
1	HomocysteineIBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Cystatin CIBA 01/2023
1	Lipoprotein(a)IBA 01/2023
1	Designed Ankyrin Repeat ProteinsIBA 01/2022

Therapy/Procedure

35	Therapeutics 05/2024 - 08/2010
23	Light Coagulation 10/2023 - 08/2008
17	Lasers (Laser) 10/2023 - 08/2008
11	Injections 12/2023 - 03/2012
6	Vitrectomy 01/2024 - 01/2018
5	Aftercare (After-Treatment) 06/2023 - 01/2018
4	Intravitreal Injections 01/2018 - 11/2008
3	Photochemotherapy (Photodynamic Therapy) 04/2023 - 07/2017
3	Slit Lamp 01/2021 - 08/2008
3	Traction 01/2018 - 11/2008
3	Laser Therapy (Surgery, Laser) 06/2016 - 09/2013
2	Semiconductor Lasers 03/2012 - 11/2010
1	Retreatment 10/2023